المؤلفون: Burbano, X., Miguez-Burbano, M. J., McCollister, K., Zhang, G., Rodriguez, A., Ruiz, P., Lecusay, Robert, Shor-Posner, G.

المصدر: HIV Clinical Trials. 3(6):483-491

مصطلحات موضوعية: HIV hospitalization, Hospitalization costs, Selenium therapy, abacavir, antiretrovirus agent, CD4 antigen, nucleoside derivative, placebo, proteinase inhibitor, RNA directed DNA polymerase inhibitor, selenium, adjuvant chemotherapy, adult, article, cell count, chemoprophylaxis, clinical trial, controlled clinical trial, controlled study, diet supplementation, dose response, double blind procedure, drug screening, drug use, female, gender, health care cost, highly active antiretroviral therapy, hospital admission, hospital cost, hospitalization, human, human cell, Human immunodeficiency virus 1, Human immunodeficiency virus infection, major clinical study, male, pilot study, priority journal, randomized controlled trial, risk assessment, time, toxicity, treatment outcome, virus load, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Chemotherapy, Adjuvant, Dietary Supplements, Double-Blind Method, Florida, HIV Infections, Hospital Costs, Humans, Middle Aged, Viral Load

وصف الملف: print

الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-27967Test

المؤلفون: Pentheroudakis, George, Batistatou, Anna, Kalogeras, K. T., Kronenwett, R., Wirtz, R. M., Bournakis, E., Eleftheraki, A. G., Pectasides, Dimitrios, Bobos, M., Papaspirou, I., Kamina, S., Gogas, H., Koutras, A. K., Pavlidis, Nicholas, Fountzilas, George

المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Pentheroudakis, George [0000-0002-6632-2462], Department of Medical Oncology, Ioannina University Hospital, Department of Pathology, School of medicine [Thessaloniki], Aristotle University of Thessaloniki-Aristotle University of Thessaloniki, Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Siemens Healthcare Diagnostics, Sividon Diagnostics GmbH, Stratifyer Molecular Pathology GmbH, Department of Clinical Therapeutics, Alexandra Hospital, University of Athens School of Medicine, Section of Biostatistics, Section of Oncology, 2nd Department of Internal Medicine, Hippokration Hospital, University of Athens School of Medicine, Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki School of Medicine, Department of Histopathology, Alexandra Hospital, 1st Department of Medicine, Laiko General Hospital, University of Athens School of Medicine, Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School

المصدر: Breast cancer research and treatment
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2011, 127 (1), pp.179-193. ⟨10.1007/s10549-011-1427-0⟩

مصطلحات موضوعية: Oncology, Β-tubulin isotype iii, Messenger rna, Progesterone receptor, Multiple cycle treatment, Breast cancer, Medicine, Protein analysis, skin and connective tissue diseases, Disease free survival, β-tubulin isotype III, Mastectomy, Gene expression regulation, Genetic transcription, Prognosis, Immunohistochemistry, Gene expression profiling, Gene Expression Regulation, Neoplastic, Retrospective study, Paclitaxel, Granulocyte colony stimulating factor, Reverse transcription polymerase chain reaction, Beta tubulin, Human, medicine.medical_specialty, Tumor gene, Major clinical study, Article, Cancer grading, Epidermal growth factor receptor 2, Prognostic/predictive factors, Humans, Predictive value of tests, RNA, Messenger, Cyclophosphamide, Survival analysis, Retrospective Studies, Aged, TUBB3, Follow up, medicine.disease, Survival Analysis, Retrospective studies, Tamoxifen, Methotrexate, chemistry, Protein expression, Gene expression, Breast neoplasms, Cancer Research, Unclassified drug, Messenger, Partial mastectomy, Beta tubulin iii, Cancer staging, chemistry.chemical_compound, Tubulin, Estrogen receptor, Overall survival, Middle aged, Priority journal, Middle Aged, Excision repair cross complementing protein 1, Female, Breast disease, Fluorouracil, Cancer tissue, Adult, Predictive value, Histopathology, Breast Neoplasms, Young Adult, Predictive Value of Tests, Internal medicine, Tau protein, Early cancer, Human tissue, Neoplasm Staging, Epirubicin, Neoplastic, Taxane, Beta tubulin iii gene, business.industry, Gene Expression Profiling, Cancer, Translational research, Genetic translation, Adjuvant chemotherapy, Drug efficacy, Outcome assessment, Young adult, Multivariate analysis, Multivariate Analysis, Neoplasm staging, Cancer patient, Rna, business, Axillary lymph node, Controlled study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec7973de11ace1d6dddf303afee14aa8Test
https://gnosis.library.ucy.ac.cy/handle/7/42338Test